| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2022 | Aug 26, 2022 | Vincerx Pharma, Inc. | Director | Buy | 91.3 | +30,000 | 300.00% | ✗ | $49.4K |
| Oct 5, 2021 | Oct 7, 2021 | Quince Therapeutics, Inc. | CFO | Sell | 26.3 | -4,963 | -7.64% | ✓ | $488.9K |
| Aug 16, 2021 | Aug 18, 2021 | Quince Therapeutics, Inc. | CFO | Sell | 5.0 | -22,000 | -42.31% | ✓ | $2.1M |
| Jun 29, 2021 | Jun 30, 2021 | Vincerx Pharma, Inc. | Director | Buy | 95.0 | +10,000 | 100.00% | ✗ | $126.2K |
| Jun 28, 2021 | Jun 30, 2021 | Quince Therapeutics, Inc. | CFO | Sell | 5.0 | -20,000 | -100.00% | ✓ | $1.1M |